F
Foundation Medicine
Transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease
At a glance
- Founded
- 2010
- Headquarters
- Boston, United States
- Listing
- IPO 2013
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Series B and later9 investors entered at this stage
- HSHarvard Medical School
- RGRedmile Group
- HUHarvard University
- BGBill Gates
Casdin Capital- RFRoche Venture Fund
- BIBroad Institute
- EJEvan Jones
- DIDana-Farber Cancer Institute
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Patents
140 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Foundation Medicine was the backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Foundation Medicine's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Foundation Medicine's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Foundation Medicine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Foundation Medicine on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.